BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Clinical trial NCT07666490 · RECRUITING
Trial details
- NCT number
- NCT07666490
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-28
- Primary completion
- 2028-06-13
- Enrollment
- 644
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.